Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EPIX | ESSA Pharma Inc. | Director | Mar 25, 2024 | |||
MYOV | Myovant Sciences Ltd. | Chief Commercial Officer | Mar 10, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|